Structure Therapeutics Inc.
GPCRFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Structure Therapeutics Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 4 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 29, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Structure Therapeutics Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-07-30 · FMR LLC (derivative): Larger than 30 of the 31 other insider sales of American Depositary Shares on file. SEC filing
- 2024-06-10 · Stevens Raymond C (derivative): Larger than all 31 other insider sales of American Depositary Shares on file. SEC filing
- 2024-03-14 · FMR LLC (derivative): Larger than 29 of the 31 other insider sales of American Depositary Shares on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-25 | Lin Xichen · CHIEF SCIENTIFIC OFFICER | American Depositary Shares | S — Open market or private sale | −7,878 | 49.08 | SEC filing |
| 2026-04-14 | FMR LLC · 10% owner, other | American Depositary Shares | S — Open market or private sale | −16,085 | 55.07 | SEC filing |
| 2026-04-14 | FMR LLC · 10% owner, other | American Depositary Shares | S — Open market or private sale | −1,367 | 55.07 | SEC filing |
| 2026-01-15 | FMR LLC · 10% owner, other | American Depositary Shares | S — Open market or private sale | −20 | 85.04 | SEC filing |
| 2026-01-15 | FMR LLC · 10% owner, other | American Depositary Shares | S — Open market or private sale | −552 | 84.22 | SEC filing |
| 2026-01-15 | FMR LLC · 10% owner, other | American Depositary Shares | S — Open market or private sale | −6,498 | 84.22 | SEC filing |
| 2026-01-15 | FMR LLC · 10% owner, other | American Depositary Shares | S — Open market or private sale | −230 | 85.04 | SEC filing |
| 2026-01-15 | FMR LLC · 10% owner, other | American Depositary Shares | S — Open market or private sale | −465 | 82.10 | SEC filing |
Showing 8 of 15 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-25 | Lin Xichen · CHIEF SCIENTIFIC OFFICER | American Depositary Shares | C — Conversion of derivative security | +7,878 | SEC filing |
| 2026-06-25 | Lin Xichen · CHIEF SCIENTIFIC OFFICER | Share Option (right to buy) | M — Exercise or conversion of derivative security | −23,634 | SEC filing |
| 2026-06-25 | Lin Xichen · CHIEF SCIENTIFIC OFFICER | Ordinary Shares | M — Exercise or conversion of derivative security | +23,634 | SEC filing |
| 2026-06-25 | Lin Xichen · CHIEF SCIENTIFIC OFFICER | Ordinary Shares | C — Conversion of derivative security | −23,634 | SEC filing |
| 2026-06-17 | DOBMEIER ERIC · Director | Share Option (right to buy) | A — Grant, award, or other acquisition | +39,453 | SEC filing |
| 2026-06-17 | TETLOW SHARON · Director | Share Option (right to buy) | A — Grant, award, or other acquisition | +39,453 | SEC filing |
| 2026-06-17 | Russell Angus C. · Director | Share Option (right to buy) | A — Grant, award, or other acquisition | +39,453 | SEC filing |
| 2026-06-17 | Waldstreicher Joanne · Director | Share Option (right to buy) | A — Grant, award, or other acquisition | +39,453 | SEC filing |
Showing 8 of 30 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2023-12-22 | FMR LLC · 10% owner, other | American Depositary Shares | J — Other acquisition or disposition | −25,410 | SEC filing |
| 2023-08-03 | WELCH DANIEL G · Director | Stock option (right to buy) | J — Other acquisition or disposition | +205,500 | SEC filing |
| 2023-08-03 | WELCH DANIEL G · Director | Stock option (right to buy) | J — Other acquisition or disposition | −411,000 | SEC filing |
| 2023-05-10 | BVF PARTNERS L P/IL · 10% owner | Ordinary Shares, $0.0001 par value per share | J — Other acquisition or disposition | −2,929,660 | SEC filing |
| 2023-05-10 | BVF PARTNERS L P/IL · 10% owner | Convertible Non-Voting Ordinary Shares | J — Other acquisition or disposition | +2,929,660 | SEC filing |
| 2023-05-10 | BVF PARTNERS L P/IL · 10% owner | Convertible Non-Voting Ordinary Shares | J — Other acquisition or disposition | +462,605 | SEC filing |
| 2023-05-10 | BVF PARTNERS L P/IL · 10% owner | Ordinary Shares, $0.0001 par value per share | J — Other acquisition or disposition | −4,018,253 | SEC filing |
| 2023-05-10 | BVF PARTNERS L P/IL · 10% owner | Ordinary Shares, $0.0001 par value per share | J — Other acquisition or disposition | −462,605 | SEC filing |
Showing 8 of 9 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.